UPDATE: Personalis, Inc. (PSNL) Tops Q2 EPS by 5c, Revenues Beat
Get Alerts PSNL Hot Sheet
Join SI Premium – FREE
Personalis, Inc. (NASDAQ: PSNL) reported Q2 EPS of ($0.29), $0.05 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $16.33 million.
Second Quarter Highlights
“I’m proud to say that we were able to report record revenues once again this quarter, with our team delivering strong execution across both our population sequencing and biopharma businesses, despite the impact from the COVID-19 pandemic, and we continued to see strong ordering levels from both our existing and new customers,” said John West, Chief Executive Officer. “In addition, our recently announced liquid biopsy product will be available to order immediately.”
For earnings history and earnings-related data on Personalis, Inc. (PSNL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Progress Software Corporation (PRGS) Issues Statement on a Possible Offer for MariaDB
Create E-mail Alert Related Categories
Corporate News, Earnings, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!